Cancer · 1974 · 72 citations · 25 references
MedicineOncologyPharmacologyCancer PharmacologyHematologic OncologyMedical OncologyAlkylating AgentsHematologic MalignanciesHematologic Malignancy TherapyMultiple MyelomaLeukemia EpidemiologyLeukemia RiskMultiple Myeloma TherapyMultiple Myeloma Treatment
Five patients in the Kansas City leukemia surveillance program had a history of multiple myeloma prior to the onset of their acute leukemia. If one applies the Kansas City age/sex-specific leukemia rates to an estimated population with multiple myeloma living in the study area during the 7-year collection period, only 0.17 patients would be expected to develop acute leukemia. The five patients presented in this paper represent a significant increase in the observed over the expected incidence. Twenty-six patients have now been reported who developed acute leukemia during treatment for multiple myeloma, and each had received an alkylating agent. These drugs may be direct leukemogens and the risk involved in their use must be recognized.
25
Multiple Myeloma and Acute Myelomonocytic Leukemia
Robert A. Kyle, Robert V. Pierre, Edwin D. Bayrd · New England Journal of Medicine · 1970 · 289 citations
Medicine, Hematology, Oncology +17
Persons with exceptionally high risk of leukemia.
Miller Rw · PubMed · 1967 · 133 citations
Medicine, Hematology, Oncology +10
Extraosseous lesions in plasma cell myeloma
George A. Edwards, Z Zawadzki · The American Journal of Medicine · 1967 · 125 citations
R W Miller · Annals of Internal Medicine · 1970 · 124 citations